Authors:
WATANABE T
NISHIYAMA M
HORI T
ASANO T
SHIMIZU T
MASAYASU H
Citation: T. Watanabe et al., EBSELEN (DR3305) AMELIORATES DELAYED CEREBRAL VASOSPASM IN A CANINE 2-HEMORRHAGE MODEL, Neurological research, 19(5), 1997, pp. 563-565
Authors:
TAKASAGO T
PETERS EE
GRAHAM DI
MASAYASU H
MACRAE IM
Citation: T. Takasago et al., NEUROPROTECTIVE EFFICACY OF EBSELEN, AN ANTIOXIDANT WITH ANTIINFLAMMATORY ACTIONS, IN A RODENT MODEL OF PERMANENT MIDDLE CEREBRAL-ARTERY OCCLUSION, British Journal of Pharmacology, 122(6), 1997, pp. 1251-1256
Authors:
NOZAWA R
ARAI M
KURUTO R
MOTOHASHI T
MASAYASU H
Citation: R. Nozawa et al., SUSCEPTIBILITY OF MICE TO BACTERIAL AND FUNGAL-INFECTIONS AFTER INTRAGASTRIC ADMINISTRATION OF EBSELEN, Journal of Pharmacy and Pharmacology, 48(1), 1996, pp. 64-67
Authors:
HATTORI R
YUI Y
SHINODA E
INOUE R
AOYAMA T
MASAYASU H
KAWAI C
SASAYAMA S
Citation: R. Hattori et al., EFFECT OF EBSELEN ON BOVINE AND RAT NITRIC-OXIDE SYNTHASE ACTIVITY ISMODIFIED BY THIOLS, Japanese Journal of Pharmacology, 72(2), 1996, pp. 191-193
Citation: Da. Dawson et al., THE NEUROPROTECTIVE EFFICACY OF EBSELEN (A GLUTATHIONE-PEROXIDASE MIMIC) ON BRAIN-DAMAGE INDUCED BY TRANSIENT FOCAL CEREBRAL-ISCHEMIA IN THE RAT, Neuroscience letters, 185(1), 1995, pp. 65-69
Authors:
HATTORI R
INOUE R
SASE K
EIZAWA H
KOSUGA K
AOYAMA T
MASAYASU H
KAWAI C
SASAYAMA S
YUI Y
Citation: R. Hattori et al., PREFERENTIAL INHIBITION OF INDUCIBLE NITRIC-OXIDE SYNTHASE BY EBSELEN, European journal of pharmacology. Molecular pharmacology section, 267(2), 1994, pp. 1-2